|
End-of-day quote
Shanghai S.E.
02/09/2026
|
5-day change | 1st Jan Change | ||
| 38.02 CNY | -1.55% |
|
-1.35% | -10.65% |
| Market Cap | 12.1B 1.8B 1.55B 1.46B 1.33B 2.49B 170B 2.51B 17.33B 6.72B 86.97B 6.76B 6.61B 286B | P/E 2024 |
11.3x | P/E 2025 | 14.6x |
|---|---|---|---|---|---|
| Enterprise Value | 9.49B 1.41B 1.22B 1.15B 1.05B 1.96B 133B 1.97B 13.59B 5.27B 68.23B 5.3B 5.19B 224B | EV / Sales 2024 |
3.4x | EV / Sales 2025 | 3.72x |
| Free-Float |
39.36% | Yield 2024 |
5.3% | Yield 2025 | 4.13% |
| 1 day | -1.55% | ||
| 1 week | -1.35% | ||
| Current month | -0.96% | ||
| 1 month | -1.71% | ||
| 3 months | -0.99% | ||
| 6 months | -10.71% | ||
| Current year | -10.65% |
| 1 week | 37.98 |  | 39.19 |
| 1 month | 37.58 | | 41.86 |
| Current year | 34.8 | | 46 |
| 1 year | 34.8 | | 57.98 |
| 3 years | 26.95 | | 57.98 |
| 5 years | 22.73 | | 57.98 |
| 10 years | 13.54 | | 140.05 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yuan Dong Guo
CEO | Chief Executive Officer | 56 | 19/11/2014 |
Jun Chen
DFI | Director of Finance/CFO | 48 | 24/10/2019 |
Li Li Wen
IRC | Investor Relations Contact | 46 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Da Bin Chen
CHM | Chairman | 70 | 07/01/2015 |
Yu Cheng Zhou
BRD | Director/Board Member | 44 | 07/01/2015 |
Yuan Dong Guo
BRD | Director/Board Member | 56 | 07/01/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.55% | -1.35% | -21.43% | -1.52% | 1.83B | |
| +0.01% | -2.47% | +57.79% | +108.23% | 1,034B | |
| +1.48% | +1.93% | +54.56% | +71.49% | 654B | |
| +0.67% | -0.45% | +23.50% | +76.60% | 459B | |
| +0.49% | -5.19% | +33.28% | +34.59% | 343B | |
| +0.27% | +3.26% | +29.76% | +46.97% | 307B | |
| +0.12% | -2.11% | +0.60% | +11.93% | 251B | |
| +1.08% | +0.57% | +54.34% | +72.51% | 237B | |
| +2.64% | -1.08% | -15.85% | -53.64% | 202B | |
| -0.21% | +1.03% | +32.74% | +95.19% | 186B | |
| Average | +0.50% | -1.55% | +24.93% | +46.23% | 367.34B | |
| Weighted average by Cap. | +0.63% | -1.31% | +38.82% | +67.27% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.81B 418M 360M 339M 309M 578M 39.45B 582M 4.02B 1.56B 20.17B 1.57B 1.53B 66.26B | 2.98B 444M 383M 361M 328M 614M 41.91B 619M 4.27B 1.66B 21.43B 1.67B 1.63B 70.39B |
| Net income | 1.05B 156M 135M 127M 116M 216M 14.78B 218M 1.51B 584M 7.56B 587M 575M 24.82B | 938M 140M 120M 113M 103M 193M 13.18B 195M 1.34B 521M 6.74B 524M 513M 22.14B |
| Net Debt | -2.35B -350M -302M -284M -259M -484M -33.05B -488M -3.37B -1.31B -16.9B -1.31B -1.29B -55.51B | -2.61B -388M -335M -315M -287M -537M -36.67B -541M -3.73B -1.45B -18.75B -1.46B -1.43B -61.59B |
Employees
671
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/09/26 | CN¥38.02 | -1.55% | 3,878,130 |
| 01/09/26 | CN¥38.62 | +0.60% | 3,054,515 |
| 31/08/26 | CN¥38.39 | -0.70% | 3,126,350 |
| 28/08/26 | CN¥38.66 | -1.10% | 3,606,760 |
| 27/08/26 | CN¥39.09 | -0.08% | 4,435,821 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 600211 Stock
Select your edition
All financial news and data tailored to specific country editions
